Table 2.
Preoperative Treatment of BP in Patients With CSTs (N=10)
| Study Variables | Frequency |
|---|---|
| Preoperative α blockade | |
| Phenoxybenzamine, (n) | 10 |
| Dose, (mg/kg/d) | 0.6 |
| Duration, (weeks) | 4.5±2.6 |
| Preoperative β blockade | |
| Atenolol, (n) | 4 |
| Dose, (mg/kg/d) | 0.4 |
| Duration, (days) | 34±14.8 |
| Propranolol, (n) | 2 |
| Dose, (mg/kg/d) | 0.8 |
| Duration, (days) | 3±0 |
| Labetalol, (n) | 4 |
| Dose, (mg/kg/d) | 2.3 |
| Duration, (days) | 11.5±9.2 |
| Preoperative volume expansion, (n) | 9 |
| Duration, (days) | 19.8±15.2 |
| Duration to achieve BP control in preparation for surgery, (weeks) | 4.5±2.6 |
Abbreviations: BP, blood pressure; CSTs, catecholamine‐secreting tumors.